Lindberg Terese, Sanmartin Berglund Johan, Wimo Anders, Qiu Chengxuan, Bohman Doris M, Elmståhl Sölve
Blekinge Institute of Technology, Karlskrona, Sweden.
Blekinge Center of Competence, Karlskrona, Sweden.
Gerontol Geriatr Med. 2024 Dec 3;10:23337214241304887. doi: 10.1177/23337214241304887. eCollection 2024 Jan-Dec.
This study examined the prevalence and long-term survival of atrial fibrillation (AF) in the older population. Data was recruited from the longitudinal SNAC study from baseline (2001-2004) for up to 10 years. The population comprised 6,904 persons (59% women) (mean age 73.9 years). The prevalence of AF was 4.9% and increased with age. The hazard ratio (HR) for death in those with AF at baseline was 1.29 during the 10-year observation period. Cox regression analysis in persons with AF ( = 341) showed that men had a higher HR for death (1.57). CHA2DS2-VASc scores were significantly associated with death within 10 years (HR 1.29/score). Any form of anticoagulant use was reported in 146 (42.8%) and was significantly associated with survival ( = .031). The prevalence of AF in the general population was almost 5%, and it shortened life expectancy by nearly 2.4 years over a 10-year period. Despite the proven efficacy of OAC therapies, our results demonstrate that AF continues to be associated with increased mortality, especially among men, and that many older people are at high risk of developing a stroke because they do not receive appropriate anticoagulant therapy. These results emphasize the need for improved preventive and therapeutic modalities.
本研究调查了老年人群中心房颤动(AF)的患病率及长期生存率。数据来自纵向SNAC研究,从基线期(2001 - 2004年)开始,随访长达10年。研究人群包括6904人(59%为女性)(平均年龄73.9岁)。AF的患病率为4.9%,且随年龄增长而增加。在10年观察期内,基线时患有AF者的死亡风险比(HR)为1.29。对AF患者(n = 341)进行的Cox回归分析显示,男性的死亡HR更高(1.57)。CHA2DS2 - VASc评分与10年内的死亡显著相关(HR 1.29/评分)。146人(42.8%)报告使用了任何形式的抗凝剂,且与生存率显著相关(P = .031)。普通人群中AF的患病率近5%,在10年期间预期寿命缩短近2.4年。尽管口服抗凝剂(OAC)疗法已被证实有效,但我们的结果表明,AF仍然与死亡率增加相关,尤其是在男性中,而且许多老年人因未接受适当的抗凝治疗而有发生中风的高风险。这些结果强调了改进预防和治疗方式的必要性。